Abstract
The value of adding a second antiepileptic drug in intractable epilepsy with complex-partial seizures was studied in a long-term prospective trial in 30 adult patients who failed to respond to the maximum use of carbamazepine, phenytoin, phenobarbital or primidone as the first drug. Based on the individual previous history of one-drug treatment, the most promising antiepileptic drug (carbamazepine, clobazam, clonazepam, phenobarbital, phenytoin, primidone, valproic acid) was added, if necessary until clinical toxicity occurred. A reduction of the seizure frequency by more than 75% was seen in only four patients (13%) exposed to a second drug in the event of failure of optimum one-drug treatment. The remaining majority of patients (87%) did not benefit from the second drug; in three patients the seizure frequency increased by more than 100%. The common practice of adding another drug in difficult-to-treat cases may need to be reconsidered until further evidence is presented that two drugs are more beneficial than one drug in the treatment of intractable epilepsy.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cereghino J. J., Brock J. T., Van Meter J. C., Penry J. K., Smith L. D., White B. G. Carbamazepine for epilepsy. A controlled prospective evaluation. Neurology. 1974 May;24(5):401–410. doi: 10.1212/wnl.24.5.401. [DOI] [PubMed] [Google Scholar]
- Gallagher B. B., Baumel I. P., Woodbury S. G., Dimicco J. A. Clinical evaluation of eterobarb, a new anticonvulsant drug. Neurology. 1975 May;25(5):399–404. doi: 10.1212/wnl.25.5.399. [DOI] [PubMed] [Google Scholar]
- Kutt H., Solomon G., Wasterlain C., Peterson H., Louis S., Carruthers R. Carbamazepine in difficult to control epileptic out-patients. Acta Neurol Scand Suppl. 1975;60:27–32. doi: 10.1111/j.1600-0404.1975.tb01384.x. [DOI] [PubMed] [Google Scholar]
- LIVINGSTON S., PETERSEN D. Primidone (mysoline) in the treatment of epilepsy; results of treatment of 486 patients and review of the literature. N Engl J Med. 1956 Feb 16;254(7):327–329. doi: 10.1056/NEJM195602162540706. [DOI] [PubMed] [Google Scholar]
- Leppik I. E., Sherwin A. L. Anticonvulsant activity of phenobarbital and phenytoin in combination. J Pharmacol Exp Ther. 1977 Mar;200(3):570–575. [PubMed] [Google Scholar]
- Reynolds E. H., Shorvon S. D. Monotherapy or polytherapy for epilepsy? Epilepsia. 1981 Feb;22(1):1–10. doi: 10.1111/j.1528-1157.1981.tb04327.x. [DOI] [PubMed] [Google Scholar]
- Rodin E. A., Rim C. S., Kitano H., Lewis R., Rennick P. M. A comparison of the effectiveness of primidone versus carbamazepine in epileptic outpatients. J Nerv Ment Dis. 1976 Jul;163(1):41–46. doi: 10.1097/00005053-197607000-00006. [DOI] [PubMed] [Google Scholar]
- Rodin E. A., Rim C. S., Rennick P. M. The effects of carbamazepine on patients with psychomotor epilepsy: results of a double-blind study. Epilepsia. 1974 Dec;15(4):547–561. doi: 10.1111/j.1528-1157.1974.tb04028.x. [DOI] [PubMed] [Google Scholar]
- Shorvon S. D., Reynolds E. H. Unnecessary polypharmacy for epilepsy. Br Med J. 1977 Jun 25;1(6077):1635–1637. doi: 10.1136/bmj.1.6077.1635. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WEAVER L. C., SWINYARD E. A., WOODBURY L. A., GOODMAN L. S. Studies on anticonvulsant drug combinations: phenobarbital and diphenylhydantoin. J Pharmacol Exp Ther. 1955 Mar;113(3):359–370. [PubMed] [Google Scholar]